The Fellowship in Pharmacy Informatics offered by the Department of Pharmacotherapy and Translational Research in the University of Florida College of Pharmacy is a two-year program for pharmacists who want to develop advanced skills in clinical practice, research, and teaching in the area of pharmacy informatics.
The fellowship is two years in length, beginning July 1 and ending June 30. The fellowship cycle starts on even-numbered years (e.g., July 2022 to June 2024)
This fellowship program is housed in the UF College of Pharmacy in Gainesville, Florida. The fellow will have the opportunity to work at three sites: the UF College of Pharmacy, UF Clinical and Translational Science Institute, and UF Health.
- Obtain Epic® certifications and badges (Inpatient pharmacist clinical tools builder, Best-Practice Advisory basic and advance badges)
- Develop and maintain clinical decision support for pharmacogenomics
- Provide informatics support for pharmacogenomics clinical trials
- Query electronic health record (EHR) data from the UF database for research requests (working with the UF Integrated Data Repository or IDR team)
- Collaborate with multiple healthcare professionals to help implement informatics applications for Artificial Intelligence research
- Develop and deliver lectures and lead topic discussions in the area of pharmacy informatics for PharmD students
- Design, initiate and conduct new research in the area of pharmacy informatics
- Publishing papers in peer-reviewed journals is expected
- Doctor of Pharmacy degree from an ACPE-accredited institution
- Expectation for Florida Pharmacist license within 6 months from the time the position starts.
- Completion of a PGY1 residency or one year of experience in clinical practice.
Interested applicants should contact the fellowship director prior to submission of application materials. All application materials should be submitted electronically by email to firstname.lastname@example.org.
The application deadline is April 1, 2022.
Required application material:
- Letter of intent (in two pages or less, describe experience and reasons for pursuing this fellowship)
- Current curriculum vitae
- Three letters of recommendation
- Unofficial transcript (from PharmD program only)
Diversity, Inclusion & Health Equity Statement
The Pharmacy Informatics Fellowship program is committed to diversity, equity, and inclusion in both the recruitment process and in the workplace. Our program is strengthened by including those from varied backgrounds, experiences, and perspectives. We hold ourselves accountable for creating an inclusive and nurturing learning environment ensuring equal opportunity for all trainees. The UF College of Pharmacy and our training program are dedicated to assisting all trainees in their pursuit of excellence as they strive to achieve their personal and professional goals.
Khoa Nguyen Pharm.D.
- Mailing Address:
PO Box 100486
GAINESVILLE FL 32610
Khoa Nguyen, Pharm.D., received his Doctor of Pharmacy degree from the University of Michigan, College of Pharmacy. He then completed a fellowship in medical informatics at the VA Indianapolis, HSR&D. After his fellowship, he joined the Regenstrief Institute, Center for Health Services Research as a research scientist and Purdue University, College of Pharmacy as a Visiting Assistant Professor. Currently, Khoa is a Clinical Assistant Professor in the Department of Pharmacotherapy and Translational Research at the University of Florida, College of Pharmacy. His clinical practice is within the UF Health Personalized Medicine Program to help develop and improve pharmacogenomic clinical decision supports. Dr. Khoa Nguyen’s research interests include human-computer interaction, pharmacogenomics, and health informatics. His research focused on improving patient safety through medication use from two approaches: qualitative research and quantitative research. Using the qualitative research approach, Dr. Nguyen wants to utilize human factor engineering and human-computer interaction method to develop and implement pharmacogenomic clinical decision supports (PGx-CDS). PGx-CDS, when implemented, can foster pharmacogenomics service to predict and prevent severe adverse drug reactions from genetic mutations. Using the quantitative research approach, he wants to identify risk factors that can increase the risk of adverse drug reactions from literature and healthcare organizations’ data. Dr. Nguyen also wants to identify subpopulations that can have genetic testing cost-effectively.
Best Poster by a Postdoctoral Fellow2018 · American Association of College of Pharmacy
Local Initiated Project Award2016-2018 · Health Services Research & Development, VA Indianapolis
Zaccardelli Family Pharmacy Scholarship2013-2015 · University of Michigan, College of Pharmacy
Strategies prescribers and pharmacists use to identify and mitigate adverse drug reactions in inpatient and outpatient care: a cognitive task analysis at a US Veterans Affairs Medical CenterBMJ Open
Implementing a pragmatic clinical trial to tailor opioids for acute pain on behalf of the IGNITE ADOPT PGx investigators.Clinical and translational science
Dosing profiles of concurrent opioid and benzodiazepine use associated with overdose risk among US Medicare beneficiaries: group‐based multi‐trajectory modelsAddiction
Clinical non-effectiveness of clopidogrel use for peripheral artery disease in patients with CYP2C19 polymorphisms: a systematic review.European journal of clinical pharmacology
Assessment of a Manual Method versus an Automated, Probability-Based Algorithm to Identify Patients at High Risk for Pharmacogenomic Adverse Drug Outcomes in a University-Based Health Insurance Program.Journal of personalized medicine
Utilizing a Human-Computer Interaction Approach to Evaluate the Design of Current Pharmacogenomics Clinical Decision Support.Journal of personalized medicine
Risk Factors for Bleeding and Clinical Ineffectiveness Associated With Clopidogrel Therapy: A Comprehensive Meta-Analysis.Clinical and translational science
Multi-Institutional Implementation of Clinical Decision Support for APOL1, NAT2, and YEATS4 Genotyping in Antihypertensive Management.Journal of personalized medicine
Recommendations for patient similarity classes: results of the AMIA 2019 workshop on defining patient similarity.Journal of the American Medical Informatics Association : JAMIA
Utilizing a user-centered approach to develop and assess pharmacogenomic clinical decision support for thiopurine methyltransferase.BMC medical informatics and decision making
- 2018 European journal of clinical pharmacology
Usability evaluation of a medication reconciliation tool: Embedding safety probes to assess users' detection of medication discrepancies.Journal of biomedical informatics
- 2017 Applied clinical informatics
Predicting Risky Opioid Therapy e-Care Tool (PROTeCT): Prototype Development and Pilot TestingUF HEALTH SHANDS HOSPITAL · Co-Investigator
Using Artificial Intelligence to Identify Patients Most Likely to Benefit from Preemptive Pharmacogenetic TestingUF HEALTH SHANDS HOSPITAL · Co-Investigator
Developing and Evaluating a Machine-Learning Opioid Prediction & Risk-Stratification E-Platform (DEMONSTRATE)NATL INST OF HLTH NIDA · Co-Investigator
IPA for Dr. Khoa NguyenUS DEPT OF VET AFF ROUDEBUSH MED CTR · Principal Investigator
Developing a Real-Time Trajectory Tool to Identify Potentially Unsafe Concurrent Opioid and Benzodiazepine Use among Older AdultsNATL INST OF HLTH NIA · Co-Investigator